Zevra Therapeutics
ZVRA
ZVRA
89 hedge funds and large institutions have $80.7M invested in Zevra Therapeutics in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 37 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
3% less capital invested
Capital invested by funds: $83.5M → $80.7M (-$2.85M)
43% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 37
Holders
89
Holding in Top 10
–
Calls
$707K
Puts
$446K
Top Buyers
| 1 | +$5.86M | |
| 2 | +$1.98M | |
| 3 | +$1.5M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$749K |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$527K |
Top Sellers
| 1 | -$1.94M | |
| 2 | -$1.76M | |
| 3 | -$337K | |
| 4 |
VF
Virtu Financial
New York
|
-$177K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$152K |